Monaldi Archives for Chest Disease

Scope & Guideline

Championing Open Access to Vital Medical Research

Introduction

Explore the comprehensive scope of Monaldi Archives for Chest Disease through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Monaldi Archives for Chest Disease in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1122-0643
PublisherPAGEPRESS PUBL
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 1993 to 2024
AbbreviationMONALDI ARCH CHEST D / Monaldi Arch. Chest Dis.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressMEDITGROUP, VIA G BELLI, 4, PAVIA 27100, ITALY

Aims and Scopes

The Monaldi Archives for Chest Disease focuses on advancing knowledge in pulmonary and cardiovascular medicine through diverse clinical, epidemiological, and therapeutic research. Its aim is to provide a platform for innovative studies that impact clinical practice and improve patient outcomes.
  1. Pulmonary Diseases Research:
    The journal emphasizes research on various pulmonary conditions, including tuberculosis, chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, contributing significantly to understanding these diseases' pathophysiology, diagnosis, and management.
  2. Cardiovascular Health Studies:
    Research related to cardiovascular diseases, including heart failure, myocardial infarction, and arrhythmias, is a core area. The journal publishes studies that explore the intersection of respiratory and cardiac health, particularly in complex cases.
  3. Infectious Diseases and Public Health:
    There is a strong focus on infectious diseases, especially tuberculosis and COVID-19, reflecting the journal's commitment to addressing global health challenges and providing insights into treatment protocols and public health strategies.
  4. Innovative Therapeutic Approaches:
    The journal highlights studies on new therapeutic interventions, including pharmacological treatments, rehabilitation strategies, and innovative surgical techniques, aimed at improving patient outcomes in respiratory and cardiovascular care.
  5. Clinical and Epidemiological Studies:
    Monaldi Archives prioritizes epidemiological research that informs clinical practice, assessing risk factors, treatment outcomes, and healthcare delivery models to enhance understanding and management of chest diseases.
Recent publications have highlighted several emerging themes in the journal, reflecting current trends in chest disease research and addressing contemporary healthcare challenges.
  1. COVID-19 Impact and Management:
    The journal has seen a surge in studies focused on the effects of COVID-19 on respiratory and cardiovascular health, including post-acute sequelae, treatment strategies, and healthcare system responses, indicating a major shift in research focus due to the pandemic.
  2. Telemedicine and Remote Patient Management:
    With the rise of telehealth during the pandemic, there is an emerging trend in studies evaluating the effectiveness of telemedicine in managing chronic respiratory and cardiovascular diseases, showcasing innovative approaches to patient care.
  3. Multidisciplinary Approaches to Treatment:
    There is a growing emphasis on multidisciplinary treatment strategies that integrate various specialties, such as pulmonology, cardiology, and rehabilitation, in managing complex patients, reflecting a trend towards holistic patient care.
  4. Environmental and Socioeconomic Factors:
    Research exploring the impact of environmental factors, such as air pollution, on respiratory diseases has gained traction, highlighting the importance of understanding social determinants of health in managing chest diseases.
  5. Personalized Medicine and Biomarkers:
    There is an increasing focus on personalized medicine, including studies on biomarkers for disease prediction and treatment response, showcasing a shift towards tailored therapeutic strategies in respiratory and cardiovascular care.

Declining or Waning

While the journal continues to cover a wide range of topics, certain areas have shown a decline in publication frequency or relevance, reflecting shifting priorities in research and clinical practice.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in studies focusing solely on traditional surgical techniques for respiratory diseases, possibly due to the rise of minimally invasive and endoscopic methods that are gaining preference in clinical practice.
  2. Basic Science and Laboratory Studies:
    Research focusing on basic science aspects of pulmonary and cardiovascular diseases is less prevalent, as the journal increasingly emphasizes clinical and translational studies that directly impact patient care.
  3. Longitudinal Studies in Chronic Diseases:
    The frequency of longitudinal studies examining chronic respiratory or cardiac conditions has waned, potentially reflecting a shift towards more immediate, short-term outcome studies in the context of recent global health crises.

Similar Journals

RESPIRATORY MEDICINE

Advancing the Frontiers of Pulmonary Health
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Egyptian Journal of Bronchology

Unveiling breakthroughs in bronchology for global impact.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Pulmonology

Unleashing the latest in pulmonary and respiratory medicine.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Minerva Respiratory Medicine

Fostering collaboration for improved respiratory outcomes.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Thoracic Research and Practice

Driving Innovation in Thoracic Health and Research
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Lung India

Connecting researchers and clinicians for impactful findings.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Shaping the future of respiratory and critical care medicine.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

Annals of Thoracic Medicine

Fostering collaboration in the pursuit of thoracic excellence.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

HEART & LUNG

Exploring the Frontiers of Cardiovascular and Respiratory Medicine
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Unveiling breakthroughs in respiratory and critical care.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.